Raymond James Financial, Inc. Reiterates Underperform Rating for Express Scripts Holding Company (ESRX)

Express Scripts Holding Company (NASDAQ:ESRX)‘s stock had its “underperform” rating reiterated by investment analysts at Raymond James Financial, Inc. in a research report issued to clients and investors on Monday.

A number of other brokerages have also recently weighed in on ESRX. Jefferies Group LLC set a $72.00 target price on shares of Express Scripts Holding and gave the stock a “buy” rating in a report on Tuesday, August 29th. BidaskClub lowered shares of Express Scripts Holding from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th. Royal Bank Of Canada started coverage on shares of Express Scripts Holding in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $68.00 price target for the company. UBS AG lowered shares of Express Scripts Holding from a “market perform” rating to an “underperform” rating in a research report on Monday. Finally, ValuEngine upgraded shares of Express Scripts Holding from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Six analysts have rated the stock with a sell rating, eleven have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $69.45.

Express Scripts Holding (NASDAQ ESRX) opened at 58.18 on Monday. The firm’s 50-day moving average is $62.17 and its 200 day moving average is $62.57. Express Scripts Holding has a 12 month low of $57.80 and a 12 month high of $77.50. The stock has a market capitalization of $33.60 billion, a P/E ratio of 10.10 and a beta of 0.88.

Express Scripts Holding (NASDAQ:ESRX) last issued its earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.71 by $0.02. The company had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The firm’s revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.57 earnings per share. On average, equities analysts anticipate that Express Scripts Holding will post $6.99 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This report was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this report on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The correct version of this report can be viewed at https://stocknewstimes.com/2017/10/11/raymond-james-financial-inc-reiterates-underperform-rating-for-express-scripts-holding-company-esrx.html.

In other news, VP Everett Neville sold 1,163 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the transaction, the vice president now owns 18,232 shares in the company, valued at approximately $1,120,903.36. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Phyllis S. Anderson sold 578 shares of the firm’s stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $63.13, for a total transaction of $36,489.14. Following the transaction, the vice president now owns 10,530 shares of the company’s stock, valued at approximately $664,758.90. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 5,641 shares of company stock valued at $357,317. Insiders own 0.68% of the company’s stock.

Several large investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of Express Scripts Holding by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock valued at $2,652,964,000 after purchasing an additional 649,400 shares in the last quarter. Dodge & Cox boosted its position in shares of Express Scripts Holding by 25.7% during the 2nd quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock valued at $2,310,275,000 after purchasing an additional 7,388,021 shares in the last quarter. State Street Corp boosted its position in shares of Express Scripts Holding by 1.1% during the 1st quarter. State Street Corp now owns 27,060,709 shares of the company’s stock valued at $1,783,569,000 after purchasing an additional 298,341 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC boosted its position in shares of Express Scripts Holding by 4.2% during the 1st quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock valued at $1,160,862,000 after purchasing an additional 704,218 shares in the last quarter. Finally, Macquarie Group Ltd. boosted its position in shares of Express Scripts Holding by 8.4% during the 2nd quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock valued at $758,480,000 after purchasing an additional 922,406 shares in the last quarter. Institutional investors own 88.69% of the company’s stock.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply